dr. holcombe discusses aflibercept for mcrc
Published 11 years ago • 153 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
2:01
dr. holcombe on the progress of colorectal cancer and regorafenib
-
1:10
dr. holcombe on the utility of stool dna test for colon cancer
-
0:53
dr. chan discusses the vegf-trap agent aflibercept
-
1:05
dr. peeters on the utility of aflibercept in advanced colorectal cancer
-
2:39
dr. ruff on the velour trial analyzing ziv-aflibercept in mcrc
-
1:50
dr. eckhardt discusses angiogenesis inhibitors in mcrc
-
11:36
panitumumab, regorafenib, and ziv-aflibercept in metastatic colorectal cancer
-
0:48
dr. marc peeters on the aflibercept toxicity profile
-
6:26
role of the vegf inhibitor aflibercept in metastatic colorectal cancer
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
0:37
is colorectal cancer preventable?
-
1:07
dr. ruff on aflibercept in elderly patients with colorectal cancer
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer
-
1:58
dr. saltz discusses chemotherapy in metastatic crc
-
3:04
treatment goals in refractory mcrc
-
1:06
comment: ftd/tpi bev ftd/tpi provides benefits for metastatic colorectal cancer patients
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc